Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment"
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Frontiers in Metabolomics".
Deadline for manuscript submissions: closed (15 October 2022) | Viewed by 5716
Special Issue Editors
Interests: cardiovascular risk; lipids; diabetes; prevention; therapy; Metabolic Syndrome; metabolism; lipoproteins; incretins; nutraceuticals
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
Special Issue in Metabolites: Lipid Metabolism Disorders Diagnosis and Therapy: Challenges and Opportunities
Special Issue in International Journal of Molecular Sciences: Feature Papers in Molecular Endocrinology and Metabolism
Special Issue in International Journal of Molecular Sciences: Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies 2.0
Special Issue in Medicina: Endocrinology in the Time of COVID-19
Special Issue in International Journal of Molecular Sciences: COVID-19, Diabetes, Obesity and Cardiometabolic Alterations: Recent Findings and Future Perspectives
Topical Collection in International Journal of Molecular Sciences: 21st Anniversary of IJMS: Advances in Molecular Endocrinology and Metabolism
Special Issue in Medicina: Mechanisms of Connection between Periodontitis and Non-communicable Chronic Diseases
Special Issue in Medicina: Modern Management and Treatment of Diabetes—Celebrating the 100th Anniversary of the First Diabetic Patient Who Received Insulin
Special Issue in Metabolites: The Role of Lipid Metabolism in Dyslipidemias and Atherosclerosis
Special Issue in Biomedicines: A Modern Approach to Cardiometabolic Diseases: Mechanisms, Biomarkers, and Therapeutic Strategies
Special Issue in International Journal of Molecular Sciences: New Advances in Metabolic Syndrome
Interests: lipids; lipoproteins; atherosclerosis; diabetes; biomarkers; laboratory diagnostics; medical biochemistry
Interests: anthropometry; obesity; diabetes; cardiovascular risk; clinical endocrinology; body composition; cardiovascular
Special Issue Information
Glucose metabolism alterations are recognized as one of the most important risk factors for the development and complications of cardiometabolic diseases.
Large epidemiological studies and clinical trials have provided over the years significant evidence that lowering fasting and post-prandial glycemia, as well as ameliorating other indices of glucose metabolism alterations, such as glycated hemoglobin, is an effective approach to reduce cardiometabolic risk.
However, several questions are still present on which parameters should be routinely evaluated in daily clinical practice, as well as on which therapies should be initiated earlier or later. This is also on current debate due to the excellent cardiometabolic risk reduction found by most, but not all, novel antidiabetic drugs. Further research is needed to fully explain the mechanisms involved in the beneficial or in the neutral cardiovascular outcome of the different agents.
In summary, with this Special Issue of Metabolites, it is our aim to critically review available evidence on some of the above listed challenges that need to be met, in order to contribute to a better understanding of glucose metabolism alterations and their effective management and prevention.
Prof. Dr. Manfredi Rizzo
Prof. Dr. Jelena Vekić
Prof. Dr. José Silva-Nunes
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- insulin resistance
- metabolic syndrome
- molecular mechanisms
- metabolic control
- cardiovascular risk factors